source
- Novartis shareholder urges board overhaul after share plunge tied to trial setbacksA prominent Novartis investor has publicly called for a revamp of the company’s board, arguing that stronger governance is needed after the stock experienced a record decline. The demand was voice…
- FDA expands approval for Bayer's lung cancer therapyThe U.S. Food and Drug Administration announced an expansion of the approved use of Bayer's lung cancer drug. The decision broadens the patient population eligible for the treatment, reflecting th…